Literature DB >> 3893572

Marrow transplantation for pancytopenia in dyskeratosis congenita.

H K Mahmoud, U W Schaefer, C G Schmidt, R Becher, G F Götz, H J Richter.   

Abstract

A 33-year-old man with dyskeratosis congenita received a marrow transplant to treat severe pancytopenia. The graft was successful-, but the patient developed severe acute graft-versus-host-disease grade IV and died 51 days postgrafting. - The outcome of transplantation in dyskeratosis congenita is compared to that in Fanconi's anaemia due to the resemblance of both diseases in some aspects.

Entities:  

Mesh:

Year:  1985        PMID: 3893572     DOI: 10.1007/bf00320601

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  4 in total

1.  Dyskeratosis congenita with pancytopenia. Another constitutional anemia.

Authors:  S Inoue; G Mekanik; M Mahallati; W W Zuelzer
Journal:  Am J Dis Child       Date:  1973-09

Review 2.  Bone marrow transplantation for Fanconi anemia.

Authors:  E Gluckman; R Berger; J Dutreix
Journal:  Semin Hematol       Date:  1984-01       Impact factor: 3.851

3.  Psoralen-DNA cross-linking photoadducts in dyskeratosis congenita: delay in excision and promotion of sister chromatid exchange.

Authors:  D M Carter; M Pan; A Gaynor; J S McGuire; L Sibrack
Journal:  J Invest Dermatol       Date:  1979-07       Impact factor: 8.551

4.  Bone marrow transplantation in Fanconi anaemia.

Authors:  E Gluckman; A Devergie; G Schaison; A Bussel; R Berger; J Sohier; J Bernard
Journal:  Br J Haematol       Date:  1980-08       Impact factor: 6.998

  4 in total
  2 in total

1.  Treatment of the hematological manifestations of dyskeratosis congenita.

Authors:  C Putterman; R Safadi; J Zlotogora; R Banura; A Eldor
Journal:  Ann Hematol       Date:  1993-04       Impact factor: 3.673

Review 2.  Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.

Authors:  Suneet Agarwal
Journal:  Hematol Oncol Clin North Am       Date:  2018-05-28       Impact factor: 3.722

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.